Oner, G., Önder, S., Karatay, H., Ak, N., Tükenmez, M., Müslümanoğlu, M., . . . Cabioğlu, N. (2021). Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy. BMC.
Chicago Style (17th ed.) CitationOner, Gizem, et al. Clinical Impact of PD-L1 Expression in Triple-negative Breast Cancer Patients with Residual Tumor Burden After Neoadjuvant Chemotherapy. BMC, 2021.
MLA (8th ed.) CitationOner, Gizem, et al. Clinical Impact of PD-L1 Expression in Triple-negative Breast Cancer Patients with Residual Tumor Burden After Neoadjuvant Chemotherapy. BMC, 2021.
Warning: These citations may not always be 100% accurate.